Cerebral metabolic changes associated with Lyme disease

Nuclear Medicine Communications

Volumn 23, Issue 8, 2002, Pages 773-777

  Newberg, A ^a   Hassan, A ^a   Alavi, A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cerebral metabolism; Lyme disease; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; AMNESIA; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DIAGNOSTIC IMAGING; FATIGUE; HEADACHE AND FACIAL PAIN; HUMAN; IMAGE ANALYSIS; LYME DISEASE; METABOLIC DISORDER; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VISUAL DISORDER; VISUAL FIELD DEFECT; BLOOD; BORRELIA BURGDORFERI; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLIC ENCEPHALOPATHY; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BORRELIA BURGDORFERI; BRAIN DISEASES, METABOLIC; COMPARATIVE STUDY; FLUDEOXYGLUCOSE F 18; HUMAN; LYME DISEASE; MIDDLE AGE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED;

EID: 0035991808     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200208000-00011     Document Type: Article

References (10)

1. Steere AC. Lyme borreliosis. In: Isselbacher KJ, Braunweld E, Wilson ID, et al., eds. Harrison's Principles of Internal Medicine, 13th Edition. New York: McGraw-Hill, 1994: 745-747.
2. Fallon BA, Das S, Plutchok JJ, et al. Functional brain imaging and neuropsychological testing in Lyme disease. Clin Inf Dis 1997; 25: S57-S63.
3. Karp JS, Freifelder R, Geagan MJ, et al. Three-dimensional imaging characteristics of the HEAD PENN-PET scanner. J Nucl Med 1997; 38: 636-643.
4. Newberg A, Alavi A, Clark C, et al. Metabolic imaging severity rating scale (MISRS) for the assessment of cerebral dysfunction in Alzheimer's disease. J Nucl Med 1997; 38: 129P.
5. Sumiya H, Kobayashi K, Mizukoshi C, et al. Brain perfusion SPECT in Lyme neuroborreliosis. J Nucl Med 1997; 38: 1120-1122.
6. Logigian EL, Johnson KA, Kijewski MF, et al. Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 1997; 49: 1661-1670.
7. Logigian EL, Kaplan RF, Steere AC. Successful treatment of Lyme encephalopathy with intravenous ceftriaxone. J lnf Dis 1999; 180: 377-383.
8. Plutchok JJ, Tikofsky RS, Liegner KB, et al. Serial brain SPECT imaging in chronic Lyme encephalopathy. J Nucl Med 1997; 38: 278P.
9. Loessner A, Alavi A, Lewandrowski KU, et al. Regional cerebral function determined by FDG-PET in healthy volunteers: Normal patterns and changes with age. J Nucl Med 1995; 36: 1141-1149.
10. Sakamoto S, Ishii K. Low cerebral glucose extraction rates in the human medial temporal cortex and cerebellum. J Neurological Sci 2000; 172: 41-48.